Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Equiceutica
United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Equiceutica is a veterinary pharmaceutical company dedicated to developing and commercializing innovative therapeutic solutions for equine health. The company's primary focus is on managing pain and inflammation associated with osteoarthritis and lameness in horses, which are leading causes of performance loss and retirement in the equine industry. Their lead product, Equioxx (firocoxib), is a non-steroidal anti-inflammatory drug (NSAID) specifically formulated for horses to provide long-lasting relief from joint pain. Equiceutica aims to improve the quality of life and athletic longevity of horses through evidence-based medicine and targeted pharmacological interventions.
- Therapeutic areas
- Rheumatology
- Modalities
- Small molecule
- Industry
- Veterinary
Beyond the preview
Go deeper on Equiceutica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Equiceutica.